JANE STREET GROUP, LLC - VERTEX PHARMACEUTICALS INC ownership

VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 8 filers reported holding VERTEX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of VERTEX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$26,482,680
-29.4%
56,500
-37.1%
0.01%
-25.0%
Q1 2024$37,537,298
+12.4%
89,800
+9.4%
0.01%
-11.1%
Q4 2023$33,405,669
-19.3%
82,100
-31.0%
0.01%
-30.8%
Q3 2023$41,381,060
+69.9%
119,000
+72.0%
0.01%
+62.5%
Q2 2023$24,352,172
-16.5%
69,200
-25.3%
0.01%
-33.3%
Q1 2023$29,175,482
+21.1%
92,600
+11.0%
0.01%
+9.1%
Q4 2022$24,084,252
-7.4%
83,400
-7.1%
0.01%0.0%
Q3 2022$26,001,000
-43.3%
89,800
-44.8%
0.01%
-42.1%
Q2 2022$45,819,000162,6000.02%
Other shareholders
VERTEX PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 130,900$30,937,0000.05%
Interchange Capital Partners, LLC 2$10,0000.01%
IMC-Chicago, LLC 10,600$2,505,0000.00%
SIMPLEX TRADING, LLC 474$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of VERTEX PHARMACEUTICALS INC shareholders